Search
Research
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or breakthrough infection, which can become refractory to antifungal treatment and has a high associated mortality. Other emerging patient risk groups include patients in the intensive care setting with severe respiratory viral infections, including COVID-19.
Research
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19Respiratory syncytial virus (RSV) remains a leading cause of mortality and morbidity worldwide. RSV seasonality was disrupted by COVID-19-associated nonpharmaceutical interventions (NPIs). We review RSV seasonality, molecular epidemiology, clinical manifestations, and community awareness to inform future prevention strategies.
News & Events
COVID tests well tolerated by WA school kidsA study conducted across 40 WA schools has found COVID-19 testing using a combined nose and throat swab was well tolerated by children as young as 4 years.
News & Events
Minderoo Foundation funds vaccine trial to protect WA healthcare workers from COVID-19At least 2,000 WA healthcare workers will help test whether an existing tuberculosis vaccine can reduce their chance of COVID-19 infection, lessen the severity of symptoms and boost immunity.
News & Events
WA’s Omicron wave on a downward trajectory, despite new variantsSophisticated modelling produced is predicting a steady decline in COVID-19 cases in WA throughout August, but hospitalisation rates will remain relatively high.
News & Events
COVID-19 in WA: Why having our kids wear masks at school is the correct callWest Australian children as young as Year 3 are now turning up to school in masks, presenting a new challenge for kids, parents and schools.
News & Events
Tips for discussing coronavirus with your kidsThe rapidly developing coronavirus crisis is affecting our daily lives in unprecedented ways and brings with it uncertainty and fear.
News & Events
Landmark research investigating benefits of COVID-19 vaccination for kids set to launch at The Kids Research Institute AustraliaA first-of-its-kind national study looking at the optimal COVID-19 vaccination strategies for children and adolescents is set to begin at Perth’s The Kids Research Institute Australia thanks to a $3.8 million funding injection from the Australian Government’s Medical Research Future Fund (MRFF).
A number of organisations have created COVID-19 resources specifically developed for Aboriginal and Torres Strait Islander people.
Research
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19.